Home / Stocks / Park Medi World Limited
PARKHOSPS

Park Medi World Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹237.08

Change

-0.96 (-0.4%)

Open

₹236.0

Prev. Close

₹238.04

Day High

₹240.99

Day Low

₹234.4

Volume Analysis

Traded

363,969

Delivered

140,181

Delivery %

38.51%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (24.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹247.17 ₹244.08 ₹240.58 ₹237.49 ₹233.99 ₹230.9 ₹227.4
Fibonacci ₹244.08 ₹241.56 ₹240.01 ₹237.49 ₹234.97 ₹233.42 ₹230.9
Camarilla ₹238.89 ₹238.29 ₹237.68 ₹237.49 ₹236.48 ₹235.87 ₹235.27

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+58.16%

1 Week

-7.3%

1 Month

+6.6%

3 Months

-13.65%

6 Months

-8.53%

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹82.02

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

11.39%

Net margin 14.7% × asset turnover 0.52x × equity multiplier 1.49x

Company Overview

Sector

Healthcare

Market Cap

₹11,039 Cr

P/E (TTM)

43.1

ROE

16.8%

Book Value

₹50.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Park Medi World Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Financial Strength (100/100), while Valuation (20/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (24.0%).

TopFund Score — Fundamentals Quality

63/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

46

Valuation

20

Cash Flow

95

Corporate Governance

39

Momentum

71

Institutional Ownership

36

Business Quality

83

Risk & Volatility

70

Liquidity

39

From Screener.in

  • −Though the company is reporting repeated profits, it is not paying out dividend

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Newspaper advertisement with respect to unaudited financial results for the quarter and half year ended September 30, 2026

Crisil final monitoring report for September 2026 shows full IPO proceeds utilized, including Rudrapur hospital acquisition.

Investor Presentation for Q2 & H1 FY''27 Unaudited Results

Park Medi World reports H1 FY27 revenue ₹9,867 mn, announces 150-bed Zirakpur acquisition and 300-bed Kanpur O&M.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 348 354 399 410 410 460 476 511
Expenses + 265 265 294 297 311 333 350 409
Operating Profit 83 88 105 113 99 127 126 102
OPM % 24.0% 25.0% 26.0% 27.0% 24.0% 28.0% 26.0% 20.0%
Other Income + 15 9 7 8 9 8 8 10
Interest 16 16 15 15 15 14 10 14
Depreciation 15 16 15 15 15 18 19 21
Profit before tax 67 66 82 91 78 103 105 76
Tax % 32.0% 20.0% 20.0% 14.0% 32.0% 26.0% 16.0% 29.0%
Net Profit + 46 52 66 79 53 77 89 54
EPS in Rs 1 1 2 2 1 2 2 1
Raw PDF — — — — — — — —
YoY Sales growth — — — — 18 30 19 25

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 766 1,084 1,255 1,231 1,394 1,679 1,857
Expenses + 457 740 863 919 1,020 1,233 1,403
Operating Profit 309 345 391 312 374 446 455
OPM % 40.0% 32.0% 31.0% 25.0% 27.0% 27.0% 24.0%
Other Income + 3 9 15 29 30 32 34
Interest 24 40 51 72 62 61 53
Depreciation 24 35 41 51 57 62 73
Profit before tax 265 278 315 218 286 355 363
Tax % 26.0% 28.0% 28.0% 30.0% 25.0% 23.0% —
Net Profit + 187 199 228 152 215 274 273
EPS in Rs 4 5 6 4 5 6 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth — 42 16 -2 13 21 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 256 380 610 806 975 1,936 2,073
Borrowings + 292 517 576 687 682 364 552
Other Liabilities + 249 319 331 343 393 411 500
Total Liabilities 816 1,293 1,593 1,912 2,127 2,797 3,211
Fixed Assets + 365 458 536 837 890 1,309 1,607
CWIP 7 29 5 32 37 123 23
Investments 0 0 0 0 0 0 0
Other Assets + 443 806 1,052 1,043 1,199 1,365 1,581
Total Assets 816 1,293 1,593 1,912 2,127 2,797 3,211
Equity Capital 19 77 77 77 77 86 86

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 223 155 199 367 215 329
Cash from Investing Activity + -233 -248 -234 -76 -100 -316
Cash from Financing Activity + 49 163 1 -130 -89 121
Net Cash Flow 39 70 -34 161 26 134
Free Cash Flow 86 64 106 299 70 209
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 96 72 76 150 80 96

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 82.89% → 82.89%
  Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 7.06% 6.98% 7.33% 8.0%
Promoters 82.89% 82.89% 82.89% 82.89%
Government 0.2% 0.3% 0.0% 0.0%
FII 1.28% 0.86% 0.82% 0.88%
DII 8.58% 8.95% 8.95% 8.23%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Park Medi World Limited (this stock) 11,039 43.1 5.12 16.8%
Akums Drugs And Pharma L 11,279 29.9 3.22 8.45%
Viyash Scientific Limited 11,285 46.6 3.56 7.39%
Metropolis Healthcare Ltd 11,711 50.7 7.13 13.6%
Symbiotec Pharmalab Ltd 10,354 70.0 7.6 11.7%
Yatharth Hosp & Tra C S L 10,222 53.6 5.44 10.2%
Blue Jet Healthcare Ltd 9,989 70.9 — 52.1%

Which Mutual Funds Hold Park Medi World Limited?

Frequently Asked Questions about Park Medi World Limited

Community Sentiment

What are other investors saying about Park Medi World Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.